QRS prolongation on surface ECG and brain natriuretic peptide as indicators of left ventricular systolic dysfunction
Authors:
Open Access
- 1 February 2004
- journal article
- website
- Published by Wiley in Journal of Internal Medicine
- Vol. 255 (2) , 206-212
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during β-blocker therapy: A potential of hormone-guided treatmentAmerican Heart Journal, 2001
- Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunctionAmerican Heart Journal, 2001
- A prolonged QRS duration on surface electrocardiogram is a specific indicator of left ventricular dysfunctionJACC, 1998
- Value of natriuretic peptides in assessment of patients with possible new heart failure in primary careThe Lancet, 1997
- Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart FailureCirculation, 1997
- The utility of clinical, electrocardiographic, and roentgenographic variables in the prediction of left ventricular functionThe American Journal of Cardiology, 1995
- Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease.Heart, 1993
- Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).Circulation, 1990
- Value of normal electrocardiographic findings in predicting resting left ventricular function in patients with chest pain and suspected coronary artery diseaseThe American Journal of Medicine, 1989
- The limited reliability of physical signs for estimating hemodynamics in chronic heart failureJAMA, 1989